Informazioni su Bicycle Therapeutics plc - American Depositary Shares Panoramica della società da Wikipedia

Wikidata ↗

BCYC Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$3.98

Capitalizzazione di Mercato

$277M

P/E (TTM)

-1.3

EPS (TTM)

$-3.16

Ricavi (TTM)

$73M

Rendimento div.

—

ROE

-34.2%

D/E Debito/Patrimonio

—

Intervallo 52 sett.

$4 – $9

BCYC Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $73M

2017-12-31 → 2025-12-31

EPS $-3.16

2019-12-31 → 2025-12-31

Flusso di cassa libero $-252M

2019-12-31 → 2025-12-31

Margini -301.7%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

BCYC

Mediana dei peer

P/E (TTM)

-1.3

—

P/S (TTM)

3.8

5.1

P/B

0.5

4.5

Price / FCF (Prezzo / FCF)

-1.1

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

BCYC

Mediana dei peer

Operating Margin (Margine Operativo)

-340.4%

—

Net Profit Margin (Margine di Profitto Netto)

-301.7%

-328.5%

ROA

-26.2%

-37.9%

ROE

-34.2%

-82.2%

ROIC

-40.5%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

BCYC

Mediana dei peer

Current Ratio (Rapporto corrente)

12.0

5.0

Quick Ratio

11.0

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

BCYC

Mediana dei peer

Revenue YoY (Ricavi YoY)

105.8%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

71.2%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

47.5%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

BCYC

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-3.16

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

BCYC

Mediana dei peer

BCYC Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 16 analisti

Acquisto forte 5 31,2%
Compra 7 43,8%
Mantieni 4 25,0%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

6 analisti · 2026-08-17

Mediana $9.50

← Sotto tutti i target $3.98

Basso $5.00

Alto $14.00

Target mediano $9.50 +138,7%

Target medio $9.50 +138,7%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.06%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.72	$-0.59	-0.13%
31 Marzo 2026	$-0.87	$-0.63	-0.24%
31 Dicembre 2025	$-0.29	$-0.96	0.67%
30 Settembre 2025	$-0.85	$-1.10	0.25%
30 Giugno 2025	$-1.14	$-0.97	-0.17%
31 Marzo 2025	$-0.88	$-0.86	-0.02%
31 Dicembre 2024	$-0.82	$-0.88	0.06%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
BCYC	$491M	-2.2	105.8%	-301.7%	-34.2%	—
AUTL	—	-1.8	644.9%	-381.4%	-109.6%	—
TLSA	—	—	—	—	—	—
OKYO	—	—	—	—	—	—
ROIV	$19.95B	-51.3	-71.6%	-3629.2%	-6.5%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15

Dati annuali Conto Economico per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue	$73M	$35M	$27M	$14M	$12M	$10M	$14M	$7M
R&D Expense	$240M	$173M	$156M	$82M	$45M	$33M	$26M	$21M
SG&A Expense	$79M	$72M	$60M	$50M	$32M	$29M	$15M	$8M
Operating Expenses	$320M	$245M	$217M	$131M	$77M	$62M	$40M	$29M
Operating Income	$-247M	$-210M	$-190M	$-117M	$-66M	$-52M	$-26M	$-22M
Interest Expense	·	·	$3M	$3M	$3M	$457.0K	·	·
Other Non-op	$28M	$36M	$11M	$2M	$-3M	$226.0K	$-5M	$-665.0K
Pretax Income	$-219M	$-174M	$-179M	$-114M	$-68M	$-52M	$-31M	$-22M
Income Tax	$152.0K	$-5M	$1M	$-2M	$-2M	$-724.0K	$-254.0K	$-396.0K
Net Income	$-219M	$-169M	$-181M	$-113M	$-67M	$-51M	$-31M	$-22M
EPS (Basic)	$-3.16	$-2.90	$-5.08	$-3.80	$-2.67	$-2.66	$-2.77	·
EPS (Diluted)	$-3.16	$-2.90	$-5.08	$-3.80	$-2.67	$-2.66	$-2.77	·
Shares (Basic)	69,279,838	58,207,593	35,592,362	29,660,659	25,061,734	19,145,938	11,045,370	·
Shares (Diluted)	69,279,838	58,207,593	35,592,362	29,660,659	25,061,734	19,145,938	11,045,370	·
EBITDA	$-241M	$-203M	$-183M	$-113M	$-64M	$-51M	$-25M	·

Stato Patrimoniale 24

Dati annuali Stato Patrimoniale per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Cash & Equivalents	$628M	$880M	$526M	$339M	$439M	$136M	$0	$0
Receivables	$0	$0	$0	$2M	$1M	$5M	$201.0K	$5M
Prepaid Expense	$19M	$13M	$11M	$9M	$8M	$5M	$5M	$2M
Current Assets	$683M	$929M	$562M	$369M	$459M	$156M	$104M	$77M
PP&E (Net)	$6M	$10M	$15M	$19M	$3M	$2M	$2M	$2M
PP&E (Gross)	·	·	$28M	$27M	$8M	$6M	$5M	$4M
Accum. Depreciation	·	·	$13M	$8M	$5M	$4M	$3M	$2M
Other Non-current Assets	$13M	$11M	$6M	$8M	$3M	$2M	$2M	$3M
Total Assets	$718M	$957M	$595M	$411M	$480M	$161M	$110M	$82M
Accounts Payable	$10M	$16M	$13M	$6M	$3M	$1M	$2M	$2M
Accrued Liabilities	$44M	$41M	$32M	$26M	$14M	$12M	$6M	$7M
Current Liabilities	$57M	$67M	$70M	$53M	$36M	$23M	$9M	$9M
Capital Leases	$14M	$4M	$9M	$11M	$12M	$426.0K	$1M	·
Other Non-current Liabilities	$1M	$1M	$5M	$4M	$3M	$3M	$2M	$897.0K
Total Liabilities	$108M	$164M	$224M	$140M	$134M	$66M	$17M	$29M
Long-term Debt	·	·	$31M	$30M	$30M	$15M	·	·
Total Debt	·	·	$31M	$30M	$30M	$15M	·	·
Common Stock	$894.0K	$890.0K	$550.0K	$387.0K	$384.0K	$266.0K	$227.0K	$10.0K
Paid-in Capital	$1.51B	$1.47B	$883M	$601M	$568M	$250M	$195M	$2M
Retained Earnings	$-900M	$-681M	$-512M	$-331M	$-218M	$-152M	$-101M	$-70M
AOCI	$-4M	$119.0K	$-1M	$387.0K	$-3M	$-3M	$-2M	$-2M
Stockholders' Equity	$610M	$793M	$371M	$271M	$346M	$95M	$93M	$-70M
Liabilities + Equity	$718M	$957M	$595M	$411M	$480M	$161M	$110M	$82M
Shares Outstanding	69,367,896	69,061,418	42,431,766	29,873,893	29,579,364	21,094,557	17,993,701	814,728

Flusso di cassa 16

Dati annuali Flusso di cassa per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
D&A	$6M	$7M	$7M	$4M	$1M	$1M	$960.0K	$712.0K
Stock-based Comp	$39M	$38M	$32M	$27M	$12M	$7M	$3M	$1M
Deferred Tax	$-850.0K	$-5M	$3M	$-5M	$-2M	$-673.0K	$-364.0K	$-378.0K
Restructuring	·	$2M	·	·	·	·	·	·
Other Non-cash	$-76M	$-36M	$78M	$1M	$40M	$26M	$-2M	·
Operating Cash Flow	$-250M	$-165M	$-61M	$-86M	$-15M	$-18M	$-29M	$-26M
CapEx	$2M	$1M	$3M	$19M	$2M	$1M	$2M	$1M
Investing Cash Flow	$-2M	$-1M	$-3M	$-19M	$-2M	$-1M	$-2M	$-1M
Net Debt Issued	·	$-32M	·	·	·	·	·	·
Stock Issued	·	$544M	$249M	$6M	$291M	$48M	·	·
Net Stock Activity	·	$544M	$249M	$6M	$8M	·	·	·
Financing Cash Flow	$-131.0K	$520M	$250M	$7M	$321M	$63M	$58M	$25M
Net Change in Cash	$-251M	$353M	$188M	$-100M	$303M	$44M	$29M	$-4M
Taxes Paid	$-717.0K	$792.0K	$562.0K	$2M	$73.0K	$124.0K	$117.0K	$73.0K
Free Cash Flow	$-252M	$-166M	$-64M	$-105M	$-17M	$-19M	$-30M	·
Levered FCF	·	·	$-67M	$-108M	$-20M	$-19M	·	·

Redditività 7

Dati annuali Redditività per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Operating Margin	-340.4%	-595.0%	-704.1%	-806.6%	-561.0%	-500.1%	-190.6%	·
Net Margin	-301.7%	-479.2%	-669.7%	-779.4%	-571.2%	-490.9%	-221.8%	·
Pretax Margin	-301.4%	-492.7%	-664.3%	-789.9%	-585.5%	-497.9%	-223.6%	·
EBITDA Margin	-331.5%	-574.6%	-679.9%	-781.1%	-548.9%	-487.8%	-183.6%	·
ROA	-26.2%	-21.8%	-35.9%	-25.3%	-20.8%	-37.6%	-31.9%	·
ROE	-34.2%	-20.8%	-45.9%	-40.2%	-25.8%	-49.8%	-32.5%	·
ROIC	-40.5%	-25.7%	-47.7%	-38.2%	-17.0%	-46.6%	-28.0%	·

Liquidità e Solvibilità 5

Dati annuali Liquidità e Solvibilità per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Current Ratio	12.0	13.8	8.1	6.9	12.7	6.7	11.8	·
Quick Ratio	11.0	13.1	7.6	6.4	12.1	0.2	0.0	·
Debt / Equity	·	·	0.1	0.1	0.1	0.2	·	·
LT Debt / Equity	·	·	0.1	0.1	0.1	0.2	·	·
Interest Coverage	·	·	-58.2	-34.9	-22.0	-113.7	·	·

Efficienza 2

Dati annuali Efficienza per BCYC
Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018
Asset Turnover		0.1	0.0	0.1	0.0	0.0	0.1	0.1	·
Receivables Turnover		·	·	26.4	9.5	3.6	3.7	5.3	·

Per Azione 6

Dati annuali Per Azione per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Book Value / Share	$8.79	$11.48	$8.74	$9.06	$11.71	$4.53	$5.18	·
Revenue / Share	$1.05	$0.61	$0.76	$0.49	$0.47	·	·	·
Cash Flow / Share	$-3.60	$-2.83	$-1.70	$-2.90	$-0.59	·	·	·
Cash / Share	$9.05	$12.74	$12.41	$11.35	$14.83	$0.00	$0.00	·
Dividend / Share	$0	$0	$0	$0	$0	·	·	·
EPS (TTM)	$-3.16	$-2.90	$-5.08	$-3.80	$-2.67	$-2.66	$-2.77	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue YoY	105.8%	30.8%	86.5%	23.6%	12.6%	·	·	·
Revenue CAGR 3Y	71.2%	44.5%	37.4%	·	·	·	·	·
Revenue CAGR 5Y	47.5%	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per BCYC
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue TTM	$73M	$35M	$27M	$14M	$12M	$10M	$14M	·
Net Income TTM	$-219M	$-169M	$-181M	$-113M	$-67M	$-51M	$-31M	·
Market Cap	$491M	$967M	$767M	$884M	$1.80B	$379M	$170M	·
Enterprise Value	·	·	$271M	$575M	$1.39B	$393M	·	·
P/E	-2.2	-4.8	-3.6	-7.8	-22.8	-6.7	-3.4	·
P/S	6.8	27.4	28.4	61.1	153.9	36.4	12.3	·
P/B	0.8	1.2	2.1	3.3	5.2	4.0	1.8	·
P / Tangible Book	0.8	1.2	2.1	3.3	5.2	4.0	·	·
P / Cash Flow	-2.0	-5.9	-12.7	-10.3	-121.7	-21.3	-5.9	·
P / FCF	-1.9	-5.8	-12.1	-8.4	-107.0	-19.9	-5.6	·
EV / EBITDA	·	·	-1.5	-5.1	-21.7	-7.8	·	·
EV / FCF	·	·	-4.3	-5.5	-82.7	-20.7	·	·
EV / Revenue	·	·	10.1	39.8	119.0	37.8	·	·
Earnings Yield	-44.6%	-20.7%	-28.1%	-12.8%	-4.4%	-14.8%	-29.4%	·

Conto Economico 15

Dati trimestrali Conto Economico per BCYC
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$629.0K	$887.0K	$48M	$12M	$3M	$10M	$4M	$3M	$9M	$20M	$5M	$5M	$11M	$5M	$3M	$3M
R&D Expense	$41M	$49M	$52M	$58M	$71M	$59M	$50M	$48M	$40M	$35M	$45M	$40M	$40M	$32M	$25M	$23M
SG&A Expense	$14M	$17M	$21M	$19M	$18M	$21M	$22M	$18M	$16M	$16M	$15M	$16M	$15M	$14M	$11M	$10M
Operating Expenses	$55M	$66M	$73M	$77M	$90M	$80M	$71M	$67M	$56M	$51M	$60M	$56M	$55M	$47M	$35M	$33M
Operating Income	$-55M	$-65M	$-25M	$-66M	$-87M	$-70M	$-68M	$-64M	$-47M	$-32M	$-54M	$-51M	$-43M	$-42M	$-32M	$-30M
Interest Expense	·	·	·	·	·	·	·	·	·	$821.0K	·	$814.0K	$821.0K	$808.0K	·	$817.0K
Other Non-op	$4M	$5M	$6M	$7M	$7M	$8M	$15M	$10M	$7M	$5M	$5M	$3M	$-9.0K	$2M	$2M	$1M
Pretax Income	$-50M	$-61M	$-19M	$-59M	$-79M	$-62M	$-53M	$-54M	$-40M	$-27M	$-49M	$-48M	$-43M	$-40M	$-30M	$-29M
Income Tax	$90.0K	$172.0K	$1M	$205.0K	$-231.0K	$-1M	$-1M	$-3M	$115.0K	$-350.0K	$320.0K	$2M	$-517.0K	$-618.0K	$-420.0K	$-238.0K
Net Income	$-50M	$-61M	$-20M	$-59M	$-79M	$-61M	$-52M	$-51M	$-40M	$-27M	$-49M	$-50M	$-43M	$-39M	$-30M	$-28M
EPS (Basic)	$-0.72	$-0.87	$-0.29	$-0.85	$-1.14	$-0.88	$-0.77	$-0.74	$-0.77	$-0.62	$-1.11	$-1.26	$-1.41	$-1.30	$-1.01	$-0.96
EPS (Diluted)	$-0.72	$-0.87	$-0.29	$-0.85	$-1.14	$-0.88	$-0.77	$-0.74	$-0.77	$-0.62	$-1.11	$-1.26	$-1.41	$-1.30	$-1.01	$-0.96
Shares (Basic)	69,804,828	69,683,471	-138,472,862	69,303,746	69,252,009	69,196,945	-105,333,390	68,988,858	51,992,034	42,560,091	-64,177,523	39,576,467	30,191,693	30,001,725	-59,269,069	29,676,021
Shares (Diluted)	69,804,828	69,683,471	-138,472,862	69,303,746	69,252,009	69,196,945	-105,333,390	68,988,858	51,992,034	42,560,091	-64,177,523	39,576,467	30,191,693	30,001,725	-59,269,069	29,676,021
EBITDA	$-55M	$-64M	·	$-66M	$-87M	$-69M	·	$-64M	$-47M	$-30M	·	$-51M	$-43M	$-40M	·	$-30M

Stato Patrimoniale 24

Dati trimestrali Stato Patrimoniale per BCYC
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$510M	$559M	$628M	$648M	$721M	$793M	$880M	$891M	$961M	$457M	$526M	$572M	$340M	$294M	$339M	$361M
Receivables	·	·	$0	·	·	$136.0K	$0	·	$233.0K	·	·	$0	$45M	$50M	·	$0
Prepaid Expense	$18M	$19M	$19M	$23M	$22M	$17M	$13M	$17M	$20M	$20M	·	$14M	$10M	$11M	·	$8M
Current Assets	$575M	$619M	$683M	$739M	$804M	$856M	$929M	$966M	$1.03B	$516M	·	$603M	$408M	$381M	·	$381M
PP&E (Net)	$5M	$6M	$6M	$7M	$8M	$9M	$10M	$12M	$12M	$13M	·	$16M	$18M	$18M	·	$16M
PP&E (Gross)	·	·	·	·	·	·	·	·	$28M	$28M	·	$27M	$28M	$27M	·	$22M
Accum. Depreciation	·	·	·	·	·	·	·	·	$17M	$15M	·	$11M	$10M	$9M	·	$6M
Other Non-current Assets	$13M	$13M	$13M	$14M	$14M	$12M	$11M	$10M	$7M	$6M	·	$5M	$12M	$11M	·	$6M
Total Assets	$607M	$652M	$718M	$764M	$832M	$884M	$957M	$997M	$1.06B	$547M	·	$639M	$454M	$429M	·	$417M
Accounts Payable	$6M	$6M	$10M	$13M	$18M	$11M	$16M	$6M	$7M	$7M	·	$8M	$5M	$3M	·	$7M
Accrued Liabilities	$39M	$40M	$44M	$44M	$45M	$34M	$41M	$39M	$28M	$26M	·	$34M	$37M	$25M	·	$18M
Current Liabilities	$48M	$49M	$57M	$69M	$77M	$58M	$67M	$56M	$70M	$50M	·	$70M	$72M	$53M	·	$42M
Capital Leases	$14M	$14M	$14M	$981.0K	$2M	$3M	$4M	$6M	$7M	$8M	·	$10M	$12M	$14M	·	$11M
Other Non-current Liabilities	$931.0K	$973.0K	$1M	$1M	$1M	$1M	$1M	$6M	$5M	$5M	·	$4M	$4M	$4M	·	$3M
Total Liabilities	$96M	$98M	$108M	$145M	$163M	$144M	$164M	$166M	$184M	$191M	·	$223M	$234M	$186M	·	$128M
Long-term Debt	·	·	·	·	·	·	·	·	$31M	$31M	·	$31M	$31M	$30M	·	$30M
Total Debt	·	·	·	·	·	·	·	·	$31M	$31M	·	$31M	$31M	$30M	·	$30M
Common Stock	$900.0K	$899.0K	$894.0K	$894.0K	$893.0K	$892.0K	$890.0K	$890.0K	$889.0K	$553.0K	·	$550.0K	$396.0K	$389.0K	·	$385.0K
Paid-in Capital	$1.53B	$1.52B	$1.51B	$1.50B	$1.49B	$1.48B	$1.47B	$1.46B	$1.45B	$895M	·	$875M	$633M	$613M	·	$590M
Retained Earnings	$-1.01B	$-961M	$-900M	$-880M	$-820M	$-742M	$-681M	$-629M	$-578M	$-538M	·	$-463M	$-413M	$-370M	·	$-301M
AOCI	$-5M	$-5M	$-4M	$-3M	$-3M	$-1M	$119.0K	$-3M	$-1M	$-778.0K	·	$3M	$-877.0K	$71.0K	·	$528.0K
Stockholders' Equity	$510M	$554M	$610M	$618M	$669M	$740M	$793M	$831M	$874M	$356M	$371M	$416M	$220M	$243M	$271M	$289M
Liabilities + Equity	$607M	$652M	$718M	$764M	$832M	$884M	$957M	$997M	$1.06B	$547M	·	$639M	$454M	$429M	·	$417M
Shares Outstanding	69,814,145	69,707,026	69,367,896	69,306,511	69,253,944	69,202,355	69,061,418	69,015,971	68,941,242	42,632,597	42,431,766	42,384,799	30,585,940	30,031,758	29,873,893	29,678,431

Flusso di cassa 15

Dati trimestrali Flusso di cassa per BCYC
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$1M
Stock-based Comp	$6M	$7M	$12M	$9M	$9M	$10M	$10M	$9M	$9M	$9M	$8M	$7M	$8M	$9M	$6M	$5M
Deferred Tax	$326.0K	$-241.0K	$843.0K	$-46.0K	$-331.0K	$-1M	$-1M	$-3M	$-110.0K	$-767.0K	$-282.0K	$7M	$-2M	$-2M	$-2M	$-1M
Restructuring	·	·	·	·	·	·	·	$2M	·	·	·	·	·	·	·	·
Other Non-cash	·	$-13M	·	·	·	$-36M	·	·	·	$-54M	·	·	·	$-16M	·	·
Operating Cash Flow	$-50M	$-66M	$-19M	$-71M	$-73M	$-86M	$-9M	$-40M	$-45M	$-71M	$-47M	$-1M	$34M	$-46M	$-30M	$-6M
CapEx	$265.0K	$713.0K	$574.0K	$674.0K	$498.0K	$604.0K	$368.0K	$435.0K	$420.0K	$12.0K	$51.0K	$502.0K	$277.0K	$2M	$1M	$3M
Investing Cash Flow	$-265.0K	$-713.0K	$-574.0K	$-674.0K	$-498.0K	$-604.0K	$-368.0K	$-435.0K	$-420.0K	$-12.0K	$-51.0K	$-502.0K	$-277.0K	$-2M	$-1M	$-3M
Stock Issued	·	·	·	·	·	·	$0	$-979.0K	·	·	$10.0K	$234M	$12M	$3M	·	·
Net Stock Activity	·	·	·	·	·	·	·	·	·	·	·	·	·	$3M	·	·
Financing Cash Flow	$-50.0K	$-54.0K	$-15.0K	$-30.0K	$-45.0K	$-41.0K	$203.0K	$-32M	$550M	$2M	$386.0K	$235M	$12M	$3M	$6M	$159.0K
Net Change in Cash	$-50M	$-69M	$-20M	$-73M	$-72M	$-87M	$-11M	$-71M	$504M	$-69M	$-46M	$232M	$47M	$-45M	$-22M	$-11M
Taxes Paid	·	·	$171.0K	$233.0K	·	·	$0	$0	·	·	$-102.0K	$0	·	·	$1M	$454.0K
Free Cash Flow	·	$-67M	·	·	·	$-87M	·	·	·	$-71M	·	·	·	$-49M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-72M	·	·	·	$-49M	·	·

Redditività 7

Dati trimestrali Redditività per BCYC
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-8673.9%	-7382.4%	·	-558.6%	-2965.8%	-703.7%	·	-2385.9%	-498.3%	-162.4%	·	·	·	-853.8%	·	-978.9%
Net Margin	-8002.1%	-6857.4%	·	-503.7%	-2703.8%	-608.9%	·	-1898.4%	-425.3%	-136.0%	·	·	·	-797.9%	·	-932.5%
Pretax Margin	-7987.8%	-6838.0%	·	-501.9%	-2711.8%	-619.8%	·	-2027.3%	-424.1%	-137.8%	·	·	·	-810.5%	·	-940.3%
EBITDA Margin	-8673.9%	-7255.1%	·	-558.6%	-2965.8%	-687.3%	·	-2385.9%	-498.3%	-153.9%	·	·	·	-822.0%	·	-978.9%
ROA	-7.0%	-7.9%	·	-6.7%	-8.4%	-8.5%	·	-6.2%	-5.3%	-5.4%	·	-9.4%	-9.5%	-8.8%	·	-8.1%
ROE	-8.5%	-9.4%	·	-8.2%	-10.2%	-11.1%	·	-8.2%	-7.3%	-8.9%	·	-14.1%	-16.0%	-13.6%	·	-12.3%
ROIC	-10.7%	-11.8%	·	-10.6%	-12.9%	-9.3%	·	-7.2%	-5.2%	-8.1%	·	-11.9%	-17.0%	-15.0%	·	-9.2%

Liquidità e Solvibilità 5

Dati trimestrali Liquidità e Solvibilità per BCYC
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	12.1	12.7	·	10.7	10.4	14.9	·	17.1	14.8	10.4	·	8.6	5.7	7.2	·	9.2
Quick Ratio	10.7	11.4	·	9.4	9.3	13.8	·	15.8	13.8	9.2	·	8.2	5.3	6.5	·	8.7
Debt / Equity	·	·	·	·	·	·	·	·	0.0	0.1	·	0.1	0.1	0.1	·	0.1
LT Debt / Equity	·	·	·	·	·	·	·	·	0.0	0.1	·	0.1	0.1	0.1	·	0.1
Interest Coverage	·	·	·	·	·	·	·	·	·	-38.6	·	-62.4	-52.5	-51.7	·	-36.4

Efficienza 2

Dati trimestrali Efficienza per BCYC
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	·	·	0.0	·	0.0
Receivables Turnover		·	·	·	·	·	0.4	·	·	0.4	·	·	·	·	0.2	·	2.1

Per Azione 6

Dati trimestrali Per Azione per BCYC
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$7.31	$7.95	·	$8.92	$9.66	$10.70	·	$12.04	$12.67	$8.35	·	$9.82	$7.20	$8.10	·	$9.75
Revenue / Share	$0.01	$0.01	·	$0.17	$0.04	$0.14	·	$0.04	$0.18	$0.46	·	·	·	$0.16	·	$0.10
Cash Flow / Share	·	$-0.95	·	·	·	$-1.25	·	·	·	$-1.67	·	·	·	$-1.55	·	·
Cash / Share	$7.31	$8.03	·	$9.35	$10.42	$11.46	·	$12.91	$13.94	$10.72	·	$13.50	$11.13	$9.78	·	$12.18
Dividend / Share	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	·	$0	$0	$0	·	$0
EPS (TTM)	$-3.58	$-3.74	·	$-3.61	$-3.53	$-3.01	·	$-3.39	$-4.06	$-4.59	·	$-4.93	$-4.57	$-4.09	·	$-3.38

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per BCYC
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$16M	$26M	·	$27M	$25M	$42M	·	$37M	$46M	$41M	·	$25M	$24M	$16M	·	$16M
Net Income TTM	$-249M	$-260M	·	$-250M	$-230M	$-178M	·	$-167M	$-159M	$-158M	·	$-160M	$-137M	$-122M	·	$-97M
Market Cap	$296M	$323M	·	$536M	$481M	$588M	·	$1.56B	$1.40B	$1.06B	·	$852M	$781M	$639M	·	$690M
Enterprise Value	·	·	·	·	·	·	·	·	$465M	$635M	·	$310M	$471M	$375M	·	$359M
P/E	-1.2	-1.2	·	-2.1	-2.0	-2.8	·	-6.7	-5.0	-5.4	·	-4.1	-5.6	-5.2	·	-6.9
P/S	18.3	12.7	·	19.6	19.3	14.1	·	42.3	30.6	25.8	·	34.5	32.9	39.5	·	44.2
P/B	0.6	0.6	·	0.9	0.7	0.8	·	1.9	1.6	3.0	·	2.0	3.5	2.6	·	2.4
P / Tangible Book	0.6	0.6	·	0.9	0.7	0.8	·	1.9	1.6	3.0	·	2.0	3.5	2.6	·	2.4
P / Cash Flow	·	-4.9	·	·	·	-6.8	·	·	·	-15.0	·	·	·	-13.8	·	·
P / FCF	·	-4.9	·	·	·	-6.8	·	·	·	-15.0	·	·	·	-13.2	·	·
EV / EBITDA	·	·	·	·	·	·	·	·	-10.0	-21.1	·	-6.1	-10.9	-9.3	·	-12.1
EV / FCF	·	·	·	·	·	·	·	·	·	-9.0	·	·	·	-7.7	·	·
EV / Revenue	·	·	·	·	·	·	·	·	10.2	15.4	·	12.6	19.8	23.2	·	23.0
Earnings Yield	-84.4%	-80.6%	·	-46.6%	-50.8%	-35.4%	·	-15.0%	-20.1%	-18.4%	·	-24.5%	-17.9%	-19.2%	·	-14.5%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$73M	$35M	$27M	$14M	$12M
Margine Operativo %	-340.4%	-595.0%	-704.1%	-806.6%	-561.0%
Utile netto	$-219M	$-169M	$-181M	$-113M	$-67M
EPS Diluito	$-3.16	$-2.90	$-5.08	$-3.80	$-2.67

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	—	—	0.1	0.1	0.1
Rapporto corrente	12.0	13.8	8.1	6.9	12.7
Quick Ratio	11.0	13.1	7.6	6.4	12.1

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-252M	$-166M	$-64M	$-105M	$-17M

Ultime notizie Notizie recenti che menzionano questa società

Morgan Stanley Aggiorna le Prospettive di Bicycle Therapeutics plc (BCYC) in un Contesto di Riorientamento della Pipeline Yahoo Finance · 4 mesi fa
RBC Capital Abbassa il suo Price Target su Bicycle Therapeutics plc (BCYC) a $7 da $11 Yahoo Finance · 4 mesi, 2 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 115 filer · $141.9M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
23 (+7 vs trimestre precedente)	12 (-13 vs trimestre precedente)	36 (-8 vs trimestre precedente)	19 (+2 vs trimestre precedente)	-669K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BAKER BROS. ADVISORS LP	$46.153.914	10.885.357	32,53%	Azioni
FCPM III SERVICES B.V.	$14.706.143	3.468.430	10,37%	Azioni
ARMISTICE CAPITAL, LLC	$14.407.520	3.398.000	10,16%	Azioni
Long Focus Capital Management, LLC	$14.037.313	3.310.687	9,89%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$6.501.616	1.533.400	4,58%	Azioni
GSK plc	$6.485.339	1.529.561	4,57%	Azioni
Qube Research & Technologies Ltd	$3.288.404	775.567	2,32%	Azioni
SCHRODER INVESTMENT MANAGEMENT GROUP	$2.555.707	615.833	1,80%	Azioni
MILLENNIUM MANAGEMENT LLC	$2.348.820	553.967	1,66%	Azioni
Peapod Lane Capital LLC	$2.281.027	537.978	1,61%	Azioni
DIADEMA PARTNERS LP	$1.961.950	462.724	1,38%	Azioni
TWO SIGMA INVESTMENTS, LP	$1.842.606	434.577	1,30%	Azioni
Aquilo Capital Management, LLC	$1.457.691	171.695	1,03%	Azioni
Birchview Capital, LP	$1.329.732	313.616	0,94%	Azioni
MOORE CAPITAL MANAGEMENT, LP	$1.166.000	275.000	0,82%	Azioni
CITADEL ADVISORS LLC	$1.129.277	266.339	0,80%	Azioni
Rangeley Capital, LLC	$1.074.840	253.500	0,76%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.042.616	245.900	0,73%	Opzione Put
TWO SIGMA ADVISERS, LP	$1.034.388	146.100	0,73%	Azioni
JANE STREET GROUP, LLC	$888.373	209.522	0,63%	Azioni
Palo Alto Investors LP	$856.014	201.890	0,60%	Azioni
Sculptor Capital LP	$839.113	197.904	0,59%	Azioni
Eversept Partners, LP	$808.632	190.715	0,57%	Azioni
PINNACLE ASSOCIATES LTD	$805.558	189.990	0,57%	Azioni
Cubist Systematic Strategies, LLC	$800.393	103.410	0,56%	Azioni
FLAX POND CAPITAL, LLC	$763.565	180.086	0,54%	Azioni
Jump Financial, LLC	$708.504	167.100	0,50%	Azioni
Point72 Asset Management, L.P.	$635.729	149.936	0,45%	Azioni
MORGAN STANLEY	$552.302	130.260	0,39%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$542.139	127.863	0,38%	Azioni
GOLDMAN SACHS GROUP INC	$514.231	121.281	0,36%	Azioni
Persistent Asset Partners Ltd	$497.157	117.254	0,35%	Azioni
XTX Topco Ltd	$465.556	109.801	0,33%	Azioni
Quadrature Capital Ltd	$441.350	104.092	0,31%	Azioni
TD Asset Management Inc	$390.046	91.992	0,27%	Azioni
MARSHALL WACE, LLP	$378.183	89.194	0,27%	Azioni
Virtus Investment Advisers, LLC	$342.545	80.789	0,24%	Azioni
NANO CAP NEW MILLENNIUM GROWTH FUND L P	$339.200	80.000	0,24%	Azioni
EntryPoint Capital, LLC	$329.630	77.743	0,23%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$315.880	74.500	0,22%	Opzione Call
Marquette Asset Management, LLC	$308.901	72.854	0,22%	Azioni
DAFNA Capital Management LLC	$273.446	64.492	0,19%	Azioni
State of Tennessee, Department of Treasury	$259.289	61.153	0,18%	Azioni
CITADEL ADVISORS LLC	$238.288	56.200	0,17%	Opzione Put
SEI INVESTMENTS CO	$223.804	52.784	0,16%	Azioni
ALPS ADVISORS INC	$216.757	51.122	0,15%	Azioni
Verdad Advisers, LP	$216.664	51.100	0,15%	Azioni
ADAR1 Capital Management, LLC	$214.705	50.638	0,15%	Azioni
JANE STREET GROUP, LLC	$151.792	35.800	0,11%	Opzione Call
SIMPLEX TRADING, LLC	$149.383	35.232	0,11%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$135.498	31.957	0,10%	Azioni
Trexquant Investment LP	$131.627	31.044	0,09%	Azioni
STATE STREET CORP	$130.715	30.829	0,09%	Azioni
WOODSTOCK CORP	$123.579	29.146	0,09%	Azioni
AXQ CAPITAL, LP	$116.040	27.368	0,08%	Azioni
JANE STREET GROUP, LLC	$113.632	26.800	0,08%	Opzione Put
D. E. Shaw & Co., Inc.	$107.938	25.457	0,08%	Azioni
Invesco Ltd.	$105.160	24.802	0,07%	Azioni
National Philanthropic Trust	$104.826	24.723	0,07%	Azioni
Forefront Analytics, LLC	$92.525	21.822	0,07%	Azioni
STIFEL FINANCIAL CORP	$86.829	20.479	0,06%	Azioni
State of New Jersey Common Pension Fund D	$85.245	20.105	0,06%	Azioni
Vontobel Holding Ltd.	$84.800	20.000	0,06%	Azioni
Aigen Investment Management, LP	$81.913	19.319	0,06%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$80.708	19.035	0,06%	Azioni
CITADEL ADVISORS LLC	$73.352	17.300	0,05%	Opzione Call
RHUMBLINE ADVISERS	$67.690	15.967	0,05%	Azioni
PORTLAND INVESTMENT COUNSEL INC.	$63.600	15.000	0,04%	Azioni
Erste Asset Management GmbH	$58.100	14.000	0,04%	Azioni
Cerity Partners LLC	$57.537	13.570	0,04%	Azioni
Schonfeld Strategic Advisors LLC	$56.810	13.399	0,04%	Azioni
Walleye Capital LLC	$55.120	13.000	0,04%	Azioni
HORIZON KINETICS ASSET MANAGEMENT LLC	$53.356	12.584	0,04%	Azioni
Aquatic Capital Management LLC	$52.334	12.343	0,04%	Azioni
Jain Global LLC	$50.880	12.000	0,04%	Azioni
Crossmark Global Holdings, Inc.	$48.344	11.402	0,03%	Azioni
Pinnacle Wealth Management Advisory Group, LLC	$46.576	10.985	0,03%	Azioni
State of Wyoming	$45.622	10.760	0,03%	Azioni
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS	$42.892	10.116	0,03%	Azioni
GAMMA Investing LLC	$32.665	7.704	0,02%	Azioni
Walleye Capital LLC	$32.648	7.700	0,02%	Opzione Call
China Universal Asset Management Co., Ltd.	$31.461	7.420	0,02%	Azioni
UBS Group AG	$20.140	4.750	0,01%	Azioni
NATIXIS	$19.997	4.645	0,01%	Azioni
Tower Research Capital LLC (TRC)	$15.557	3.669	0,01%	Azioni
BARCLAYS PLC	$13.352	3.149	0,01%	Azioni
ROYAL BANK OF CANADA	$11.000	2.500	0,01%	Azioni
Mirae Asset Global Investments Co., Ltd.	$8.840	2.085	0,01%	Azioni
ACADIAN ASSET MANAGEMENT LLC	$8.319	1.968.025	0,01%	Azioni
GROUP ONE TRADING LLC	$8.217	1.938	0,01%	Azioni
ASSETMARK, INC	$6.733	1.588	0,00%	Azioni
CITIGROUP INC	$4.982	1.175	0,00%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$4.308	1.016	0,00%	Azioni
GF FUND MANAGEMENT CO. LTD.	$4.079	962	0,00%	Azioni
PRICE T ROWE ASSOCIATES INC /MD/	$3.826	902.150	0,00%	Azioni
JPMORGAN CHASE & CO	$3.598	867	0,00%	Azioni
JONES FINANCIAL COMPANIES LLLP	$2.870	700	0,00%	Azioni
Quarry LP	$2.277	537	0,00%	Azioni
HighMark Wealth Management LLC	$1.844	435	0,00%	Azioni
Arax Advisory Partners	$1.289	304	0,00%	Azioni

Insider aziendali 26 insider · 13 dirigenti · 11 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Kevin Lee	CHIEF EXECUTIVE OFFICER	06 Luglio 2026 S	603.671	2	$-32.700
Travis Alvin Thompson	Chief Financial Officer	15 Luglio 2026 A	64.441	2	$-3.945
Alethia Young	Chief Financial Officer	02 Gennaio 2024 A	12.000	0	$0
Lee Kalowski	President and CFO	03 Aprile 2023 S	30.309	0	$0
Jennifer Scott Perry	Chief Operating Officer	15 Luglio 2026 A	91.052	3	$-6.054
Alistair Milnes	Chief Operating Officer	02 Gennaio 2024 A	73.196	0	$0
Michael Charles Ferguson Hannay	CHIEF PROD & SUPPLY CHAIN OFF	15 Luglio 2026 A	94.375	2	$-7.530
Michael Skynner	CHIEF SCIENTIFIC OFFICER	15 Luglio 2026 A	157.171	2	$-10.231
Nigel Crockett	Chief Business Officer	02 Gennaio 2024 A	48.716	0	$0
Nicholas Keen	Chief Scientific Officer	02 Gennaio 2024 A	63.593	0	$0
Santiago Arroyo	Chief Development Officer	02 Gennaio 2024 A	17.340	0	$0
Dominic Smethurst	Chief Medical Officer	03 Gennaio 2023 A	36.699	0	$0
Peter Brian Leone	Chief Business Officer	28 Maggio 2019 A	—	0	$0
Janice Bourque	Direttore	02 Gennaio 2024 A	16.750	0	$0
Gregory Paul Winter	Direttore	02 Gennaio 2024 A	180.677	0	$0
Jose-Carlos Gutierrez-Ramos	Direttore	02 Gennaio 2024 A	16.750	0	$0
Pierre Legault	Direttore	02 Gennaio 2024 A	33.500	0	$0
Richard N Kender	Direttore	02 Gennaio 2024 A	16.750	0	$0
Veronica Gh Jordan	Direttore	02 Gennaio 2024 A	16.750	0	$0
Kate Bingham	Direttore	14 Luglio 2021 S	38.708	0	$0
Carolyn Ng	Direttore	28 Maggio 2019 C	1.427.151	0	$0
Deborah Harland	Direttore	28 Maggio 2019 C	1.915.275	0	$0
Michael Anstey	Direttore	28 Maggio 2019 C	1.751.437	0	$0
Cambridge Innovation Capital (Jersey) Ltd	Proprietario del 10%	28 Maggio 2019 C	1.751.437	0	$0
Vertex Global Healthcare Fund I Pte Ltd.	Proprietario del 10%	28 Maggio 2019 C	1.621.168	0	$0
GSK plc	—	15 Luglio 2020 S	1.910.531	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 7 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×3 depositi	17 Dicembre 2024	—	Deposito iniziale	—	SEC
GSK plc	20 Luglio 2023	—	Deposito iniziale	—	SEC
Tybourne Capital Management (HK) Limited, Tybourne Capital Management Limited, Tybourne Kesari Limited, Viswanathan Krishnan, Aquila Investments IV ×4 depositi	14 Marzo 2022	—	Deposito iniziale	—	SEC
GlaxoSmithKline plc ×5 depositi	16 Settembre 2021	—	Deposito iniziale	—	SEC
SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P. ×2 depositi	16 Agosto 2021	—	Deposito iniziale	—	SEC
Vertex Venture Holdings Ltd., Vertex Global HC Fund I Pte. Ltd., Vertex Venture Management Pte. Ltd. ×2 depositi	20 Gennaio 2021	—	Deposito iniziale	Investimento passivo	SEC
Cambridge Innovation Capital (Jersey) Limited	07 Giugno 2019	—	Deposito iniziale	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 6 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
BBC · ETFis Series Trust I	0,47%	37.047 NS	30 Aprile 2026	N-PORT
QQQS · Invesco Exchange-Traded Fund Trust …	0,44%	23.841 SH	08 Agosto 2026	Giornaliero
SBIO · ALPS ETF Trust	0,15%	51.450 NS	31 Maggio 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	2.516 SH	08 Agosto 2026	Giornaliero
IBB · iShares Trust	0,01%	272.825 SH	08 Agosto 2026	Giornaliero
BIB · ProShares Trust	0,01%	1.711 NS	31 Maggio 2026	N-PORT

Informazioni su Bicycle Therapeutics plc - American Depositary Shares Panoramica della società da Wikipedia

BCYC Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

BCYC Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

BCYC Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 115 filer · $141.9M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 26 insider · 13 dirigenti · 11 direttori

Attivisti e proprietari del 5%+ 7 partecipazioni

Proprietà ETF Posseduti da 6 ETF